Mora Kallner
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Co-authors
- Kjell Hellström (11 shared papers)Kurt Einarsson (9 shared papers)Bo Angelin (1 shared paper)B Beermann (3 shared papers)Kurt Bergström (1 shared paper)G Lundh (1 shared paper)Lars-Olof Eriksson (1 shared paper)
- Journals
- European Journal of Clinical Investigation (3 papers)Metabolism (2 papers)Scandinavian Journal of Gastroenterology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Clinica Chimica Acta (1 paper)
- Partner nations
- Sweden
In The Last Decade
Mora Kallner
14 papers receiving 334 citations
Peers
Comparison fields: 5 of 36
- Clinical Biochemistry 92
- Oncology 226
- Pharmacology 58
- Epidemiology 158
- Surgery 186
Countries citing papers authored by Mora Kallner
This map shows the geographic impact of Mora Kallner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mora Kallner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mora Kallner more than expected).
Fields of papers citing papers by Mora Kallner
This network shows the impact of papers produced by Mora Kallner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mora Kallner. The network helps show where Mora Kallner may publish in the future.
Co-authors
The 7 scholars most cited alongside Mora Kallner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 115 | |
| 2 | 1974 | 53 | |
| 3 | 1973 | 47 | |
| 4 | 1973 | 35 | |
| 5 | 1976 | 32 | |
| 6 | 1974 | 22 | |
| 7 | 1974 | 22 | |
| 8 | The effect of chenodeoxycholic acid feeding on bile acid kinetics and fecal neutral steroid excretion in patients with hyperlipoproteinemia types II and IV. | 1975 | 22 |
| 9 | 1974 | 22 | |
| 10 | 1974 | 16 | |
| 11 | 1973 | 11 | |
| 12 | 1987 | 9 | |
| 13 | 1986 | 2 | |
| 14 | [Liver damage in connection with ajmaline treatment]. | 1973 | 2 |
| 15 | 1985 | 1 |
About Mora Kallner
Mora Kallner is a scholar working on Oncology, Surgery, Epidemiology, Clinical Biochemistry and Pharmacology, having authored 15 papers that have together received 411 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Metabolism and Genetic Disorders (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Cholesterol and Lipid Metabolism (4 papers), Inflammatory mediators and NSAID effects (2 papers), Pediatric Hepatobiliary Diseases and Treatments (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper) and Potassium and Related Disorders (1 paper). The work is most often cited by research in Clinical Biochemistry (92 citations), Oncology (226 citations), Pharmacology (58 citations), Epidemiology (158 citations) and Surgery (186 citations). Mora Kallner has collaborated with scholars based in Sweden. Frequent co-authors include Kjell Hellström, Kurt Einarsson, Bo Angelin, B Beermann, Kurt Bergström, G Lundh and Lars-Olof Eriksson. Their work appears in journals such as European Journal of Clinical Investigation, Metabolism, Scandinavian Journal of Gastroenterology, Clinical Pharmacology & Therapeutics and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.